产品编号：S253152
产品规格：2.5mg
产品价格：面议
| 标准品编号: | S253152 |
| 名称: | Selexipag-d8 |
| 别名: | 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide-d8; 2-[4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide-d8; ACT 293987-d8; NS 304-d8; Uptravi-d8; 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy-1,1,2,2,3,3,4,4-d8]-N-(methylsulfonyl)-acetamide |
| CAS号: | 1265295-16-6 |
| 参考CAS号: | Unlabelled: 475086-01-2 |
| 分子式: | C₂₆H₂₄D₈N₄O₄S |
| 分子量: | 504.67 |
| 类别: | Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Selexipag-d8 is a labelled version of Selexipag (S253150) which is an orally available, highly selective, long-acting prostacyclin (IP) receptor agonist prodrug. It is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans. |
| 参考文献 | |
